PazAresLab's profile picture. Research group @CNIOStopCancer and H12O led by @LuisPaz_Ares. Exploring new therapies for lung cancer. Tweets by Itziar Otano

Paz-Ares's Lab

@PazAresLab

Research group @CNIOStopCancer and H12O led by @LuisPaz_Ares. Exploring new therapies for lung cancer. Tweets by Itziar Otano

Paz-Ares's Lab أعاد

Esperanza para las inmunodeficiencias primarias🔬🩸 👉🏻Una terapia experimental salva la vida de más de medio centenar de niños con una enfermedad letal. Léelo en @el_pais elpais.com/ciencia/2025-1…


Paz-Ares's Lab أعاد

Parte del grupo @CNIOStopCancer en el #ASEICACongress, con las pilas científicas recargadísimas! @ASEICAnews

msmelanoma's tweet image. Parte del grupo @CNIOStopCancer en el #ASEICACongress, con las pilas científicas recargadísimas! 
@ASEICAnews

Paz-Ares's Lab أعاد

🎯Buscamos #TecnicoAnatomiaPatologica en @PazAresLab con experiencia en IHQ, procesado de muestras FFPE, frescas y biopsia líquida. Toda la info ⬇️

CmIlung's tweet image. 🎯Buscamos #TecnicoAnatomiaPatologica en
@PazAresLab

con experiencia en IHQ, procesado de muestras FFPE, frescas y biopsia líquida. 

Toda la info ⬇️

🔝Great discussions in #aseicacongress 🔴 T-cell activation in NSCLC 🔵 TLS structures in SCLC 🟡 Chemoresistance in SCLC @UAI_imas12 @CNIOStopCancer @CIBER_ISCIII @unicomplutense

PazAresLab's tweet image. 🔝Great discussions in #aseicacongress 
🔴 T-cell activation in NSCLC
🔵 TLS structures in SCLC
🟡 Chemoresistance in SCLC
@UAI_imas12 @CNIOStopCancer @CIBER_ISCIII @unicomplutense
PazAresLab's tweet image. 🔝Great discussions in #aseicacongress 
🔴 T-cell activation in NSCLC
🔵 TLS structures in SCLC
🟡 Chemoresistance in SCLC
@UAI_imas12 @CNIOStopCancer @CIBER_ISCIII @unicomplutense
PazAresLab's tweet image. 🔝Great discussions in #aseicacongress 
🔴 T-cell activation in NSCLC
🔵 TLS structures in SCLC
🟡 Chemoresistance in SCLC
@UAI_imas12 @CNIOStopCancer @CIBER_ISCIII @unicomplutense

Paz-Ares's Lab أعاد

People at #ASEICACongress ‼️ Visit our poster #149 and find out our last findings in SCLC immune microenvironment. Tomorrow morning session 🤙🏼🤙🏼 #ASEICACongress @PazAresLab @SOSCLC_AECC @CmIlung

AcUcero's tweet image. People at #ASEICACongress ‼️
Visit our poster #149 and find out our last findings in SCLC immune microenvironment. Tomorrow morning session 🤙🏼🤙🏼
#ASEICACongress
@PazAresLab 
@SOSCLC_AECC 
@CmIlung

🟢Come and visit our poster #aseicacongress 🔬ADC and payloads

PazAresLab's tweet image. 🟢Come and visit our poster
#aseicacongress  
🔬ADC and payloads

Paz-Ares's Lab أعاد

Our REPAIRome study finally out today in @ScienceMagazine !!! science.org/doi/10.1126/sc…


Paz-Ares's Lab أعاد

🚀 First-time a drug improves OS after 1L platinum-based chemotherapy in #SCLC and breaks the 12 months OS in maintenance setting. 💊 Lurbinectedin + atezolizumab is now @US_FDA approved. 💪 Another step forward! #LCSM @SclcSMASHERS @PhrmMar fda.gov/drugs/resource…


Paz-Ares's Lab أعاد

A new Science #Immunology study describes a potent interleukin-21 mimic that can stimulate cytotoxic T cells and shows strong #antitumor activity in mouse models of cancer and in tumor explants derived from patients with #melanoma. scim.ag/3KsvCy9

SciImmunology's tweet image. A new Science #Immunology study describes a potent interleukin-21 mimic that can stimulate cytotoxic T cells and shows strong #antitumor activity in mouse models of cancer and in tumor explants derived from patients with #melanoma. scim.ag/3KsvCy9

Paz-Ares's Lab أعاد

A new Science #Immunology Review discusses the nuances of #cancer immunotherapies that target inhibitory #ImmuneCheckpoints and examines avenues for improved strategies and outcomes. @VeilletteAndre scim.ag/4myNhBy

SciImmunology's tweet image. A new Science #Immunology Review discusses the nuances of #cancer immunotherapies that target inhibitory #ImmuneCheckpoints and examines avenues for improved strategies and outcomes. @VeilletteAndre scim.ag/4myNhBy

💚Ayer Rita, Pablo e Irene participaton en la noche de los investigadores 💚 Por un futuro con ciencia e investigación🔬🧬 @CNIOStopCancer @unicomplutense @UAI_imas12 @CIBER_ISCIII

PazAresLab's tweet image. 💚Ayer Rita, Pablo e Irene participaton en la noche de los investigadores 💚
Por un futuro con ciencia e investigación🔬🧬
@CNIOStopCancer 
@unicomplutense 
@UAI_imas12 
@CIBER_ISCIII

Paz-Ares's Lab أعاد

Case series of tumor lysis syndrome with the bispecific T-cell engager tarlatamab in patients with small cell lung cancer @ClinicalLung. I have not seen this myself, but for various reasons, tarlatamab in #SCLC could be better with lower disease burden. clinical-lung-cancer.com/article/S1525-…


Paz-Ares's Lab أعاد

Interested in tertiary lymphoid structures (TLSs)? Check out our latest review, where we chart how TLSs form across organs and contexts — from lung to liver, CNS, skin, gut & more — and their dual roles in protection vs. pathology. Fun collaboration with the Linterman lab. Huge…


Paz-Ares's Lab أعاد

Mismatch Repair Deficiency: From DNA repair failure to immunotherapy sensitivity 🌊 Loss of MMR → microsatellite instability → hypermutation → abundant neoantigens 🛡️ Immune context: TIL-rich & inflamed, but immune checkpoints (PD-1, CTLA4, LAG3) and fibrotic stroma…

jsoriamd's tweet image. Mismatch Repair Deficiency: From DNA repair failure to immunotherapy sensitivity
🌊     Loss of MMR → microsatellite instability → hypermutation → abundant neoantigens
🛡️     Immune context: TIL-rich & inflamed, but immune checkpoints (PD-1, CTLA4, LAG3) and fibrotic stroma…

Paz-Ares's Lab أعاد

🗣️Entrevista a Ángel Carracedo, coordinador de #IMPaCTGenómica en @radio5_rne 🔗rtve.es/play/audios/a-… Genómica de precisión equitativa para el diagnóstico de #enfermedadesraras y #cánceres hereditarios🔬 #CIBER


Paz-Ares's Lab أعاد

We are seeking a motivated candidates to apply for the next AECC calls and join our team at INIBIC/CHUAC (A Coruña): contraelcancer.es/es/area-invest… @chuaconco, @charocampelo, @fertorresandon


Paz-Ares's Lab أعاد

📢¿Eres paciente, familiar o parte de una asociación? Webinario #IMPaCTGenómica para pacientes ⬇️ 🗓️ Lunes 29/09 | ⏰ 17:30 📍 Online | Inscripción obligatoria 🔗forms.office.com/pages/response…

CIBER_ISCIII's tweet image. 📢¿Eres paciente, familiar o parte de una asociación?

Webinario #IMPaCTGenómica para pacientes ⬇️

🗓️ Lunes 29/09 | ⏰ 17:30
📍 Online | Inscripción obligatoria
🔗forms.office.com/pages/response…

Paz-Ares's Lab أعاد

#ScienceSaturday ❓Why are naked mole-rats so resistant to cancer, and what can that teach us about human tumors? ➡️ In a new study, @LabKissil (@MoffittNews) and colleagues developed the first lung cancer model in naked mole-rats where tumors formed inside the animals’ own…

PatrickHwuMD's tweet image. #ScienceSaturday

❓Why are naked mole-rats so resistant to cancer, and what can that teach us about human tumors?

➡️ In a new study, @LabKissil (@MoffittNews) and colleagues developed the first lung cancer model in naked mole-rats where tumors formed inside the animals’ own…

Paz-Ares's Lab أعاد

📍La Semana de la Ciencia de ASEICA 2025 comenzará con... ⚫RETREAT #ASEICAMed Keynote🗣️Ignacio Melero @ClinicaNavarra @CIMA_unav 📅7OCT 🏟️Bilbao ▶️Ciencia y Networking ‼️ Posibilidad de Registro único o a todo el #ASEICACongress aseica.es/aseicamed-retr…

ASEICAnews's tweet image. 📍La Semana de la Ciencia de ASEICA 2025 comenzará con...

⚫RETREAT #ASEICAMed

Keynote🗣️Ignacio Melero @ClinicaNavarra @CIMA_unav

📅7OCT
🏟️Bilbao
▶️Ciencia y Networking
‼️ Posibilidad de Registro único o a todo el #ASEICACongress

aseica.es/aseicamed-retr…

Paz-Ares's Lab أعاد

🗣️ Del laboratorio al hospital: la investigación, clave para ofrecer el mejor tratamiento. @LuisPaz_Ares apuesta por equipos multidisciplinares y centros integrales de cáncer. @H12Octubre @AstraZeneca @SanidadeXunta @ASEICAnews Su visión completa aquí ⬇️asomega.es/actualidad/not…


Loading...

Something went wrong.


Something went wrong.